BOLD - Boundless Bio Inc Sales Growth YoY (Last Twelve Months)

Public company logo of Boundless Bio Inc (BOLD)

Boundless Bio, Inc. (BOLD) is a recognized leader in developing targeted DNA drugs for the therapy of complex oncological diseases. The scaling potential here is immense: a unified technological base allows for the launch of a series of high-margin products. Operating revenue dynamics YoY (TTM) confirm current growth rates, where 0.00 reflects the latest metric value. However, early-stage trials and a high burn rate create significant financial risks.

Sales Growth YoY (Last Twelve Months): Boundless Bio, Inc. (BOLD) for 11/23/2025 - 11/15/2026

Boundless Bio Inc. (BOLD) - metric breakdowns and financial figures

- stock quotes and analyst forecast:
Price Performance Chart Boundless Bio, Inc|BOLD - Analyst Consensus Forecast
- market capitalization statistics:
Market Value Boundless Bio, Inc.|BOLD - Enterprise Value
- business book valuation details:
Net Assets per Share Boundless Bio|BOLD - Company Book Value|Market-to-Book Ratio boundlessbio.com|BOLD - Cumulative Company Assets
- business debt structure and liquidity details:
All Debt to Shareholders' Equity Ratio Boundless Bio, Inc.|BOLD - Long-Term Debt to Capital|Short-Term Debt to Capital Coefficient Boundless Bio Inc.|BOLD - Company Debts|Debt to Book Value Ratio Boundless Bio, Inc.|BOLD - Company Long-Term Debts|Company Current Liabilities Boundless Bio|Interim Coverage Ratio boundlessbio.com
- company profitability and valuation multiples indicators:
BOLD - Net Profit|Expected Profit Boundless Bio, Inc.|BOLD - Price to Earnings Ratio|Projected Price to Earnings Ratio boundlessbio.com|BOLD - Price/Earnings to Growth Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Boundless Bio, Inc.|BOLD - Operating profit EBITDA|Earnings per share for the last 12 months Boundless Bio|BOLD - Net earnings per share (EPS TTM)|Year-over-year earnings per share growth for the last 12 months boundlessbio.com|BOLD - Earnings per share growth in current year|Projected earnings per share growth rate for next year Boundless Bio, Inc.
- sales and revenue data:
BOLD - Revenue and Sales Volume|Projected Sales Volume Boundless Bio, Inc|BOLD - P/S Multiple|Price-to-Projected Revenue Ratio Boundless Bio Inc.|BOLD - Sales Growth YoY (Last Twelve Months)
Analysis of all company metrics:Boundless Bio, Inc - BOLD
Brand item of Boundless Bio

This indicator assesses business expansion rates by comparing current trailing twelve-month (TTM) revenue with the same period from the previous cycle. Analyzing the TTM sales volume change allows for the identification of demand stability while excluding random operational fluctuations. The calculation is based on the percentage difference in total revenues over a twelve-month interval. For Boundless Bio, Inc. (BOLD), growth in this metric would signify a successful market entry. The key driver will be the commercialization of innovative drugs targeting ecDNA in oncology therapy.

Who Boundless Bio, Inc. competes with

Annual Revenue Growth (Last Twelve Months) Tempus AI, Inc (TEM)|QGEN: Revenue Growth YoY (Last 12 Months)|Ionis Pharmaceuticals (IONS) - Revenue Growth YoY (Last 12 Months)|Repligen (RGEN) - Sales Growth YoY (Last Twelve Months)|Revenue Growth YoY (Last 12 Months) Avidity Biosciences, Inc.|Sales Growth YoY (Last Twelve Months) CRISPR Therapeutics|WGS - Revenue Growth Rate YoY (Last Twelve Months)|Sales Growth YoY (TTM) RARE|Revenue Change YoY (Last 12 Months) BEAM|Sales Growth YoY (TTM) SRPT (Sarepta Corp)|TWST - Revenue Growth YoY (Last 12 Months)|TXG: Revenue Growth YoY (Last 12 Months)|Trailing Twelve Months Revenue Growth Intellia Therapeutics|STOK: Sales Growth YoY (TTM)|BLFS - Annual Revenue Growth (Last Twelve Months)|Revenue Growth YoY (Last 12 Months) WVE|MAZE: Revenue Dynamics YoY (Last Twelve Months)|Sales Growth YoY (Last Twelve Months) Sionna Corp (SION)|Annual Revenue Growth (Last Twelve Months) Prime Medicine Bio|Sales Growth YoY (TTM) TSHA (Taysha Gene Therapies Inc)|Sales Growth YoY (TTM) uniqure.com QURE|MeiraGTx Holdings - Sales Growth YoY (TTM)|RGNX - Sales Growth YoY (TTM)|SLDB (Solid Corp) - Revenue Growth YoY (Last 12 Months)|Revenue Growth Rate YoY (Last Twelve Months) Ocugen Corp OCGN|PACB (Pacific Biosciences) - Sales Growth YoY (TTM)|Sales Growth YoY (Last Twelve Months) BNTC|Sales Growth YoY (TTM) DSGN|Revenue Growth YoY (Last 12 Months) Rocket Pharma RCKT|Annual Revenue Growth (Last Twelve Months) FDMT|Sales Growth YoY (TTM) Lexeo Therapeutics LXEO|KRRO - Sales Growth YoY (Last Twelve Months)|EDIT (Editas Medicine, Inc.) - Sales Growth YoY (Last 12 Months)|SLN: Sales Growth YoY (TTM)|ProQR - Revenue Dynamics YoY (Last Twelve Months)|CDXS (Codexis) - Sales Growth YoY (TTM)|Sangamo (SGMO) - Annual Revenue Growth (Last Twelve Months)|Sales Growth YoY (TTM) NAUT|Revenue Growth YoY (Last 12 Months) Metagenomi, Inc. MGX|Sales Growth YoY (Last Twelve Months) Precision BioSciences DTIL|Revenue Dynamics YoY (Last Twelve Months) GBIO|XCUR: Revenue Growth YoY (Last 12 Months)|Imunon (IMNN) - Revenue Growth YoY (Last 12 Months)|PHIO (RXi Pharmaceuticals) - Revenue Growth YoY (Last 12 Months)|MBIO (Mustang Bio Inc) - Sales Growth YoY (Last Twelve Months)|Sales Growth YoY (Last Twelve Months) TransCode Therapeutics, Inc.|Sales Growth YoY (TTM) bionanogenomics.com|Sales Growth YoY (TTM) APDN|Sales Growth YoY (Last Twelve Months) BLUE (Bluebird Bio)|Sales Growth YoY (Last Twelve Months) ImmunoPrecise Antibodies Ltd. IPA|Revenue Dynamics YoY (Last Twelve Months) OMGA|singulargenomics.com - Sales Growth YoY (TTM)|Regulus Therapeutics Inc. - Revenue Change YoY (Last 12 Months)|SYRS: Sales Growth YoY (TTM)|Sales Growth YoY (Last 12 Months) TBIO|TCON (TRACON Pharmaceuticals) - Sales Growth YoY (TTM)|Sales Growth YoY (Last 12 Months) UBX (unitybiotechnology.com)